Taking inventory: antibacterial agents currently at or beyond phase 1.
Bush
Karen
K
Johnson and Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, USA. kbush@prdus.jnj.com
Macielag
Mark
M
Weidner-Wells
Michele
M
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans
D000900:Anti-Bacterial Agents